Milatuzumab

(別名: hLL1; MEDI-115)
7 Cited Publications
カスタマーレビュー

Based on 7 publication(s) in Google Scholar

Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度 : 99.39%
  • CAS 番号: 899796-83-9
  • 分子量:145.66 kDa
  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • 生物活性
  • 化学情報
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
Customer Validation & Images
Cell Imaging/StainingWBFlow CytometryIF
  • Cell Imaging/Staining
  • WB
  • IF
  • Flow Cytometry
  • Flow Cytometry
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00